Joseph Domachowske
Pediatric Infectious Diseases · Syracuse, NYNPI 1720007651
Payments from drug & device makers
Across 771 payments — averaging $5963.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.3M
- Modernatx, Inc.$995K
- GSK$956K
- AstraZeneca$670K
- Sanofi Pasteur Inc.$437K
- Astrazeneca UK Limited$195K
- plus $85K from 6 others
Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
What the payments were for
- Consulting fees$74,53816%
- Speaking & faculty fees$326,90570%
- Travel & lodging$63,04513%
- Food & beverage$5,7901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 48 | $1,258,801 |
| Modernatx, Inc. | 123 | $994,833 |
| GSK | 201 | $956,073 |
| AstraZeneca | 91 | $670,288 |
| Sanofi Pasteur Inc. | 223 | $437,352 |
| Astrazeneca UK Limited | 16 | $195,075 |
| Merck | 49 | $46,464 |
| Sanofi | 6 | $22,013 |
| Shionogi Inc | 3 | $7,524 |
| Novavax Inc | 9 | $7,206 |
| Abbott | 1 | $1,100 |
| Seqirus USA Inc | 1 | $875 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEYFORTUS$156,283
- BEXSERO$97,127
- FLUZONE QUADRIVALENT$7,943
- NOVAVAX COVID-19 VACCINE, ADJUVANTED$7,086
- PENTACEL$4,922
- QUADRACEL$3,684
- ENFLONSIA$3,480
- FLUZONE HIGH-DOSE$3,361
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE$2,995
- DISEASE STATE$2,214
- Moderna Covid-19 Vaccine$1,620
- PENMENVY$1,500
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE$414
- NO PRODUCT DISCUSSED$115
How this compares
$4,597,605 in reported general payments places this provider in the 95th percentile of 73 pediatric infectious diseases providers in New York.
See all pediatric infectious diseases providers in New York →
Other pediatric infectious diseases in Syracuse
- Leonard WeinerSyracuse$4.9M
- Sharon NachmanStony Brook$47.6M
- Jennifer NayakRochester$1.8M
- Mary CasertaRochester$1.6M
- Lisa SaimanNew York$927K
- Leonard KrilovMineola$580K
- Paul SueNew York$572K
- Jana ShawWatertown$346K
- Sallie PermarNew York City$257K
- Mark HicarBuffalo$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.